Clinical Trial Update: Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial evaluating the oral pediatric formulation of famciclovir in children aged 1-12 years with varicella (chick…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster
• Varicella

Drugs mentioned

• Famciclovir (famciclovir)

Snippet

Sponsor: Novartis | Conditions: Chickenpox, Herpes Zoster | Phase 3 | Status: COMPLETED